Index to Volume 149 Author Index* A Chuang L-Y (see Chen et al). 2007;149:274-281 Abraham R (see Martin et al). 2007;149:231-235 Chugh SS. Transcriptional regulation of podocyte disease. 2007; 149: Adachi M (see Kasama et al). 2007;149:265-273 237-242 Adams PC (see Steiner et al). 2007;149:92-95 Clark RJ (see Martin et al). 2007;149:231-235 Agren JJ (see Gylling et al). 2007;149:310-316 Cohen L (see Neuman et al). 2007;149:126-136 Al-Ghazali R (see Ruixing et al). 2007;149:152-160 Cohen L (see Neuman et al). 2007;149:243-253 Alston SM, Solen KA, Broderick AH, Sukavaneshvar S$, Mohammad Conley YP (see Rodway et al). 2007;149:76-84 SF. New method to prepare autologous fibrin glue on demand. Cozzi E, Wingard CJ, Cascio WE, Devlin RB, Miles JJ, Bofferding 2007;149:187-195 AR, Lust RM, Van Scott MR, Henriksen RA. Effect of ambient Altimari A (see Nanni et al). 2007;149:137-144 particulate matter exposure on hemostasis. 2007;149:324-332 Alvarez F (see Lapierre et al). 2007;149:107-113 Culebras JM (see Mauriz et al). 2007;149:46-53 Anuurad E (see Lu et al). 2007;149:317-323 Arruda JAL (see Singh et al). 2007;149:282-291 D Asai S (see Ishii et al). 2007;149:298-303 da Cunha V (see Martin-McNulty et al). 2007;149:70-75 Devlin RB (see Cozzi et al). 2007;149:324-332 B Dick R (see Hou et al). 2007;149:260-264 Bacchi L (see Nanni et al). 2007;149:137-144 Do G-M (see Jeon et al). 2007;149:15-21 Béland K (see Lapierre et al). 2007;149:107-113 Dudek AZ (see Keshtgarpour and Dudek). 2007;149:103-106 Ben-Ari Z (see Neuman et al). 2007;149:126-136 Dunea G (see Singh et al). 2007;149:282-291 Benhamou J-P (see Neuman et al). 2007;149:126-136 Duran MC (see Mauriz et al). 2007;149:46-53 Berglund L (see Lu et al). 2007;149:317-323 Bofferding AR (see Cozzi et al). 2007;149:324-332 E Bone N (see Martin et al). 2007;149:231-235 Eckfeldt JH (see Steiner et al). 2007;149:92-95 Bourliere M (see Neuman et al). 2007;149:126-136 Edwards CQ (see Phillips et al). 2007;149:85-91 Bradfield JF (see Shibata et al). 2007;149:62-69 Eng H-L (see Yang et al). 2007;149:31-36 Bradwell A (see Martin et al). 2007;149:231-235 F Branzi A (see Nanni et al). 2007;149:137-144 Fayos JL (see Martin de Llano et al). 2007;149:1-9 Breborowicz A, Polubinska A, Breborowicz M, Simon M, Wanic- Firbas C (see Mayr et al). 2007;149:10-14 Kossowska M, Oreopoulos DG. Peritoneal effects of intravenous Fish J (see Neuman et al). 2007;149:243-253 iron sucrose administration in rats. 2007;149:304-309 Forgione A (see Miele et al). 2007;149:114-125 Breborowicz M (see Breborowicz et al). 2007;149:304-309 Frank CF, Hostetter MK. Cleavage of E-cadherin: a mechanism for Brewer GJ (see Hou et al). 2007;149:260-264 disruption of the intestinal epithelial barrier by Candida albicans. Broderick AH (see Alston et al). 2007;149:187-195 2007; 149:211-222 Cc Fuertes G (see Martin de Llano et al). 2007;149:1-9 Cameron RG (see Neuman et al). 2007;149:126-136 G Cartotto R (see Neuman et al). 2007;149:243-253 Garcia-Vicent C (see Martin de Llano et al). 2007;149:1-9 Cascio WE (see Cozzi et al). 2007;149:324-332 Gasbarrini G (see Miele et al). 2007;149:114-125 Cervi V (see Nanni et al). 2007;149:137-144 Geyer SM (see Martin et al). 2007;149:231-235 Chen H-C (see Chen et al). 2007;149:274-281 Gomez M (see Neuman et al). 2007;149:243-253 Chen J-C (see Yang et al). 2007;149:31-36 Gonzalez P (see Mauriz et al). 2007;149:46-53 Chen S-C, Guh J-Y, Chen H-C, Yang Y-L, Huang J-S, Chuang L-Y. Gonzalez-Gallego J (see Mauriz et al). 2007;149:46-53 Advanced glycation end-product-induced mitogenesis is depen- Grieco A (see Miele et al). 2007;149:114-125 dent on Janus kinase 2-induced heat shock protein 70 in normal Gudehithlu KP (see Singh et al). 2007;149:282-291 rat kidney interstitial fibroblast cells. 2007;149:274-281 Guh J-Y (see Chen et al). 2007;149:274-281 Chen S-H (see Chien et al). 2007;149:96-102 Gylling H, Hallikainen M, Kolehmainen M, Toppinen L, Pihlajamaki Chiem A (see Lu et al). 2007;149:317-323 J, Mykkiinen H, Agren JJ, Rauramaa R, Laakso M, Miettinen TA. Chien C-C, Chen S-H, Liu C-C, Lee C-L, Yang R-N, Yang S-H, Cholesterol synthesis prevails over absorption in metabolic syn- Huang C-J. Correlation of K-ras codon 12 mutations in human drome. 2007;149:310-316 feces and ages of patients with colorectal cancer (CRC). 2007; 149:96-102 H Choi AMK (see Rodway et al). 2007;149:76-84 Haber J (see Neuman et al). 2007;149:243-253 Choi M-S (see Jeon et al). 2007;149:15-21 Hallikainen M (see Gylling et al). 2007;149:310-316 Hanemaaijer R (see Nanni et al). 2007;149:137-144 Harada N (see Mizuochi et al). 2007;149:223-230 *January, pp. 1-54; February, pp. 55-102; March, pp. 103-164; April, Havel PJ (see Lu et al). 2007;149:317-323 pp. 165-236; May, pp. 237-292; June, pp. 293-342. Henriksen RA (see Cozzi et al). 2007;149:324-332 Translational Research 344 Author Index June 2007 Henriksen RA (see Shibata et al). 2007;149:62-69 Lee C-L (see Chien et al). 2007;149:96-102 Hill CP (see Phillips et al). 2007;149:85-91 Leiendecker-Foster C (see Steiner et al). 2007;149:92-95 Ho Hong S (see Mantaring et al). 2007;149:205-210 Leitner JM (see Mayr et al). 2007;149:10-14 Hoffman LA (see Rodway et al). 2007;149:76-84 Lin T-M (see Yang et al). 2007;149:31-36 Hostetter MK (see Frank and Hostetter). 2007;149:21 1-222 Litaker D, Watts B, Samaan R, Ober S, Lawrence RH. Are provider Hou G, Dick R, Zeng C, Brewer GJ. Antitumor and antiinflammatory self-efficacy and attitudes related to cardiovascular prevention effects of tetrathiotungstate in comparison with tetrathiomolyb- associated with better treatment outcomes? 2007;149:165-172 date. 2007; 149:260-264 Litbarg NO (see Singh et al). 2007;149:282-291 Houweling AH (see Varady et al). 2007;149:22-30 Liu C-C (see Chien et al). 2007;149:96-102 Huang C-J (see Chien et al). 2007;149:96-102 Lu G, Chiem A, Anuurad E, Havel PJ, Pearson TA, Ormsby B, Huang J-S (see Chen et al). 2007;149:274-281 Berglund L. Adiponectin levels are associated with coronary artery disease across Caucasian and African-American ethnicity. I 2007;149:317-323 Ishii Y, Kohno T, Ito A, Suzuki S, Kohno T, Takayama T, Asai S. Lurbe E (see Martin de Llano et al). 2007;149:1-9 Measurement of extra-pancreatic secretory function by '*C- Lust RM (see Cozzi et al). 2007;149:324-332 dipeptide breath test. 2007;149:298-303 Isozaki T (see Kasama et al). 2007;149:265-273 M Ito A (see Ishii et al). 2007;149:298-303 Malavalli A (see Young et al). 2007;149:333-342 Malkiewicz IM (see Neuman et al). 2007;149:126-136 J Malkiewicz IM (see Neuman et al). 2007;149:243-253 Jagri¢ T, Marhl M, Stajer D, Kocjanéit S$ T, Jagri¢ T, Podbregar M, Mantaring M, Rhyne J, Ho Hong S, Miller M. Genotypic variation in Perc M. Irregularity test for very short electrocardiogram (ECG) ATP-binding cassette transporter-1 (ABCA/) as contributors to signals as a method for predicting a successful defibrillation in the high and low high-density lipoprotein-cholesterol (HDL-C) patients with ventricular fibrillation. 2007;149:145-151 phenotype. 2007;149:205-210 Jagrié T (see Jagrié et al). 2007;149:145-151 Marcellin P (see Neuman et al). 2007;149:126-136 Jeon S-M, Kim HK, Kim H-J, Do G-M, Jeong T-S, Park YB, Choi Marhl M (see Jagrié et al). 2007;149:145-151 M-S. Hypocholesterolemic and antioxidative effects of naringe- Martin W, Abraham R, Shanafelt T, Clark RJ, Bone N, Geyer SM. nin and its two metabolites in high-cholesterol fed rats. 2007;149: Katzmann JA, Bradwell A, Kay NE, Witzig TE. Serum-free 15-21 light chain—a new biomarker for patients with B-cell non- Jeong T-S (see Jeon et al). 2007;149:15-21 Hodgkin lymphoma and chronic lymphocytic leukemia. 2007; Jilma B (see Mayr et al). 2007;149:10-14 149:231-235 Jones PJH (see Varady et al). 2007;149:22-30 Martin de Llano JJ, Fuertes G, Garcfa-Vicent C, Torré I, Fayos JL, K Lurbe E. Procedure to consistently obtain endothelial and smooth Kadowaki T (see Shimazaki et al). 2007;149: 196-204 muscle cell cultures from umbilical cord vessels. 2007;149:1-9 Kasama T, Isozaki T, Odai T, Matsunawa M, Wakabayashi K, Martin-McNulty B, Zhang L, da Cunha V, Vincelette J, Rutledge JC, Takeuchi HT, Matsukura S, Adachi M, Tezuka M, Kobayashi K. Vergona R, Sullivan ME, Wang Y-X. Urokinase-type plasmino- Expression of angiopoietin-1 in osteoblasts and its inhibition by gen activator deficiency (uPA—KO) prevented carotid artery liga- tumor necrosis factor-alpha and interferon-gamma. 2007;149: tion-induced vascular remodeling in mice. 2007;149:70-75 265-273 Matsukura S (see Kasama et al). 2007;149:265-273 Katsuya H (see Mizuochi et al). 2007;149:223-230 Matsunawa M (see Kasama et al). 2007;149:265-273 Katz GG (see Neuman et al). 2007;149:126-136 Mauriz JL, Gonzalez P, Duran MC, Molpeceres V, Culebras JM, Katzmann JA (see Martin et al). 2007;149:231-235 Gonzalez-Gallego J. Cell-cycle inhibition by TNP-470 in an in Kay NE (see Martin et al). 2007;149:231-235 vivo model of hepatocarcinoma is mediated by a p53 and p21 VAFYCIPl mechanism. 2007;149:46-53 Keshtgarpour M, Dudek AZ. SU-011248, a vascular endothelial growth factor receptor-tyresine kinase inhibitor, controls chronic Mayr FB, Spiel AO, Leitner JM, Firbas C, Kliegel T, Jilma B. Ethnic psoriasis. 2007;149:103-106 , differences in plasma levels of interleukin-8 (IL-8) and granulo- Kim H-J (see Jeon et al). 2007;i149:15-21 cyte colony stimulating factor (G-CSF). 2007;149:10-14 Kim HK (see Jeon et al). 2007;149:15-21 McLaren CE (see Steiner et al). 2007;149:92-95 Kliegel T (see Mayr et al). 2007;149:10-14 McLaren GD (see Steiner et al). 2007;149:92-95 Kobayashi K (see Kasama et al). 2007;149:265-273 Meier P (see Seitz and Meier). 2007;149:293-297 Kocjanéit § T (see Jagrié et al). 2007;149:145-151 Melandri G (see Nanni et al). 2007;149:137-144 Kohno T (see Ishii et al). 2007;149:298-303 Miele L, Forgione A, Gasbarrini G, Grieco A. Noninvasive assess- Kohno T (see Ishii et al). 2007;149:298-303 ment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and Kolehmainen M (see Gylling et al). 2007;149:310-316 non-alcoholic steatohepatitis (NASH). 2007;149:114-125 Komura H (see Mizuochi et al). 2007;149:223-230 Miettinen TA (see Gylling et al). 2007;149:310-316 Krivoy N (see Neuman et al). 2007;149:243-253 Miles JJ (see Cozzi et al). 2007;149:324-332 Kubota K (see Shimazaki et al). 2007;149:196-204 Miller M (see Mantaring et al). 2007;149:205-210 Kushner JP (see Phillips et al). 2007;149:85-91 Mizuochi Y, Okajima K, Harada N, Molor-Erdene P, Uchiba M, Komura H, Tsuda T, Katsuya H. Carvedilol, a nonselective L B-blocker, suppresses the production of tumor necrosis factor and Laakso M (see Gylling et al). 2007;149:310-316 tissue factor by inhibiting early growth response factor-1 expres- Lapierre P, Béland K, Alvarez F. Pathogenesis of autoimmune hep- sion in human monocytes in vitro. 2007;149:223-230 atitis: from break of tolerance to immune-mediated hepatocyte Mohammad SF (see Alston et al). 2007;149:187-195 apoptosis. 2007;149:107-113 Molor-Erdene P (see Mizuochi et al). 2007;149:223-230 Lawrence RH (see Litaker et al). 2007;149:165-172 Molpeceres V (see Mauriz et al). 2007;149:46-53 Translational Research Volume 149, Number 6 Author Index 345 Morgan M (see Neuman et al). 2007;149:126-136 S Mukerjee P (see Ostrow and Mukerjee ). 2007;149:37-45 Samaan R (see Litaker et al). 2007:149:165-172 Mykkinen H (see Gylling et al). 2007;149:310-316 Sanders MH (see Rodway et al). 2007;149:76-84 Myrvik QN (see Shibata et al). 2007;149:62-69 Schmilovitz-Weiss H (see Neuman et al). 2007;149:126-136 Seitz HK, Meier P. The role of acetaldehyde in upper digestive tract N cancer in alcoholics. 2007;149:293-297 Nanni S, Melandri G, Hanemaaijer R, Cervi V, Tomasi L, Altimari A, Sereika SM (see Rodway et al). 2007;149:76-84 Van Lent N, Tricoci P, Bacchi L, Branzi A. Matrix metallopro- Sethi JM (see Rodway et al). 2007;149:76-84 teinases in premature coronary atherosclerosis: influence of in- Sethupathi P (see Singh et al). 2007;149:282-291 hibitors, inflammation, and genetic polymorphisms. 2007;149: Shanafelt T (see Martin et al). 2007;149:231-235 137-144 Shapiro LE (see Neuman et al). 2007;149:243-253 Neuman M, Nicar M. Apoptosis in ibuprofen-induced Stevens—John- Shear NH (see Neuman et al). 2007;149:243-253 son syndrome. 2007;149:254-259 Shibata Y, Ohata H, Yamashita M, Tsuji S, Bradfield JF, Nishiyama Neuman MG. Immune dysfunction in inflammatory bowel disease. A, Henriksen RA, Myrvik QN. Immunologic response enhances 2007;149:173-186 atherosclerosis—type | helper T cell (Th1)-to-type 2 helper T cell Neuman MG, Benhamou J-P, Marcellin P, Valla D, Malkiewicz IM, (Th2) shift and calcified atherosclerosis in Bacillus Calmette- Katz GG, Trepo C, Bourliere M, Cameron RG, Cohen L, Morgan Guerin (BCG)-treated apolipoprotein E-knockout (apo E ‘) M, Schmilovitz-Weiss H, Ben-Ari Z. Cytokine—chemokine and mice. 2007;149:62-69 apoptotic signatures in patients with hepatitis C. 2007;149:126- Shimazaki T, Kadowaki T, Ohyama Y, Ohe K, Kubota K. Hemoglo- 136 bin Alc (HbAIc) predicts future drug treatment for diabetes Neuman MG, Shear NH, Malkiewicz IM, Taeri M, Shapiro LE, mellitus: a follow-up study using routine clinical data in a Japa- Krivoy N, Haber J, Gomez M, Fish J, Cartotto R, Cohen L. nese university hospital. 2007;149:196-204 Immunopathogenesis of hypersensitivity syndrome reactions to Simon M (see Breborowicz et al). 2007;149:304-309 sulfonamides. 2007;149:243-253 Singh AK, Gudehithlu KP, Patri S, Litbarg NO, Sethupathi P, Arruda Nicar M (see Neuman and Nicar). 2007;149:254-259 JAL, Dunea G. Impaired integration of endothelial progenitor Nishiyama A (see Shibata et al). 2007;149:62-69 cells in capillaries of diabetic wounds is reversible with vascular endothelial growth factor infusion. 2007;149:282-291 Oo Snively BM (see Steiner et al). 2007;149:92-95 Ober S (see Litaker et al). 2007:149:165-172 Solen KA (see Alston et al). 2007;149:187-195 Spiel AO (see Mayr et al). 2007;149:10-14 Odai T (see Kasama et al). 2007;149:265-273 Stadtmueller BM (see Phillips et al). 2007;149:85-91 Ohata H (see Shibata et al). 2007:149:62-69 Stajer D (see Jagrié et al). 2007;149:145-151 Ohe K (see Shimazaki et al). 2007;149:196-204 Steiner M, Leiendecker-Foster C, McLaren GD, Snively BM, Ohyama Y (see Shimazaki et al). 2007;149:196-204 McLaren CE, Adams PC, Eckfeldt JH. Hemochromatosis (HFE) Okajima K (see Mizuochi et al). 2007;149 gene splice site mutation IVS5+1 G/A in North American Viet- Oreopoulos DG (see Breborowicz et al). 2007;149:304-309 namese with and without phenotypic evidence of iron overload. Ormsby B (see Lu et al). 2007;149:317-323 Ostrow JD, Mukerjee P. Solvent partition of '*C-unconjugated bili- 2007:149:92-95 Subbiah MTR. Nutrigenetics and nutraceuticals: the next wave riding rubin to remove labeled polar contaminants. 2007;149:37-45 on personalized medicine. 2007;149:55-61 P Sukavaneshvar S (see Alston et al). 2007;149:187-195 Sullivan ME (see Martin-McNulty et al). 2007;149:70-75 Park YB (see Jeon et al). 2007;149:15-21 Suzuki S (see Ishii et al). 2007;149:298-303 Patri S (see Singh et al). 2007;149:282-291 Pearson TA (see Lu et al). 2007;149:317-323 T Perc M (see Jagri€é et al). 2007;149:145-151 Taeri M (see Neuman et al). 2007;149:243-253 Phillips JD, Whitby FG, Stadtmueller BM, Edwards CQ, Hill CP, Takayama T (see Ishii et al). 2007;149:298-303 Kushner JP. Two novel uroporphyrinogen decarboxylase Takeuchi HT (see Kasama et al). 2007;149:265-273 (URO-D) mutations causing hepatoerythropoietic porphyria Tezuka M (see Kasama et al). 2007;149:265-273 (HEP). 2007;149:85-91 Tomasi L (see Nanni et al). 2007;149:137-144 Pihlajamiki J (see Gylling et al). 2007;149:310-316 Toppinen L (see Gylling et al). 2007;149:310-316 Podbregar M (see Jagrié et al). 2007:149:145-151 Torré I (see Martin de Llano et al). 2007;149:1-9 Polubinska A (see Breborowicz et al). 2007;149:304-309 Trepo C (see Neuman et al). 2007;149:126-136 Tricoci P (see Nanni et al). 2007:149:137-144 R Tsuda T (see Mizuochi et al). 2007;149:223-230 Rauramaa R (see Gylling et al). 2007;149:310-316 Tsuji S (see Shibata et al). 2007;149:62-69 Rhyne J (see Mantaring et al). 2007;149:205-210 U Rodway GW, Sethi JM, Hoffman LA, Conley YP, Choi AMK, Uchiba M (see Mizuochi et al). 2007;149:223-230 Sereika SM, Zullo TG, Ryter SW, Sanders MH. Hemodynamic and molecular response to intermittent hypoxia (IH) versus con- Vv tinuous hypoxia (CH) in normal humans. 2007;149:76-84 Valla D (see Neuman et al). 2007;149:126-136 Ruixing Y, Wenwu L, Al-Ghazali R. Trimetazidine inhibits cardio- Van Lent N (see Nanni et al). 2007;149:137-144 myocyte apoptosis in a rabbit model of ischemia-reperfusion. Van Scott MR (see Cozzi et al). 2007;149:324-332 2007:149: 152-160 Vandegriff KD (see Young et al). 2007;149:333-342 Rutledge JC (see Martin-McNulty et al). 2007;149:70-75 Varady KA, Houweling AH, Jones PJH. Effect of plant sterols and Ryter SW (see Rodway et al). 2007;149:76-84 exercise training on cholesterol absorption and synthesis in Translational Research 346 Author Index June 2007 previously sedentary hypercholesterolemic subjects. 2007;149: Y 22-30 Yamashita M (see Shibata et al). 2007;149:62-69 Vergona R (see Martin-McNulty et al). 2007;149:70-75 Yang R-N (see Chien et al). 2007;149:96-102 Vincelette J (see Martin-McNulty et al). 2007;149:70-75 Yang S-H (see Chien et al). 2007;149:96-102 WwW Yang Y-F, Wang Y-H, Chen J-C, Eng H-L, Lin T-M. Prevalence of RHD 1227A and hybrid Rhesus box in the general Chinese Wakabayashi K (see Kasama et al). 2007;149:265-273 population. 2007;149:31-36 Wang Y-H (see Yang et al). 2007;149:31-36 Yang Y-L (see Chen et al). 2007;149:274-281 Wang Y-X (see Martin-McNulty et al). 2007;149:70-75 Young MA, Malavalli A, Winslow N, Vandegriff KD, Winslow RM. Wanic-Kossowska M (see Breborowicz et al). 2007;149:304-309 Toxicity and hemodynamic effects after single dose administra- Watts B (see Litaker et al). 2007;149: 165-172 tion of MalPEG-hemoglobin (MP4) in rhesus monkeys. 2007; Wenwu L (see Ruixing et al). 2007;149:152-160 149:333-342 Whitby FG (see Phillips et al). 2007;149:85-91 Wingard CJ (see Cozzi et al). 2007;149:324-332 z Winslow N (see Young et al). 2007;149:333-342 Zeng C (see Hou et al). 2007;149:260-264 Winslow RM (see Young et al). 2007;149:333-342 Zhang L (see Martin-McNulty et al). 2007;149:70-75 Witzig TE (see Martin et al). 2007;149:231-235 Zullo TG (see Rodway et al). 2007;149:76-84 subject Index* A Antioxidants Hypocholesterolemic and antioxidative effects of naringenin and Acetaldehyde its two metabolites in high-cholesterol fed rats (Jeon et al). The role of acetaldehyde in upper digestive tract cancer in alco- 2007;149:15-21 holics (Seitz and Meier). 2007;149:293-7 Apolipoprotein E Adiponectin Immunologic response enhances atherosclerosis—type | helper T Adiponectin levels are associated with coronary artery disease across Caucasian and African-American ethnicity (Lu et al). cell (Th1)-to-type 2 helper T cell (Th2) shift and calcified 2007;149:317-23 atherosclerosis in Bacillus Calmette-Guerin (BCG)-treated apolipoprotein E-knockout (apo E~’~) mice (Shibata et al). Advanced glycation end products; see Glycosylation end-products, 2007; 149:62-9 advanced Apoptosis African continental population groups Ethnic differences in plasma levels of interleukin-8 (IL-8) and Apoptosis in ibuprofen-induced Stevens-Johnson syndrome granulocyte colony stimulating factor (G-CSF) (Mayr et al). (Neuman and Nicar). 2007;149:254-9 2007; 149: 10-4 Cytokine—chemokine and apoptotic signatures in patients with hepatitis C (Neuman et al). 2007;149:126-36 Air pollutants Pathogenesis of autoimmune hepatitis: from break of tolerance to Effect of ambient particulate matter exposure on hemostasis (Cozzi et al). 2007;149:324-32 immune-mediated hepatocyte apoptosis (Lapierre et al). 2007; 149:107-13 (Review) Alcoholism Trimetazidine inhibits cardiomyocyte apoptosis in a rabbit model The role of acetaldehyde in upper digestive tract cancer in alco- of ischemia-reperfusion (Ruixing et al). 2007;149:152-60 holics (Seitz and Meier). 2007;149:293-7 Atherosclerosis Amyloid precursor protein secretases; see Endopeptidases Immunologic response enhances atherosclerosis—type | helper T Angiogenesis inhibitors cell (Th1)-to-type 2 helper T cell (Th2) shift and calcified Cell-cycle inhibition by TNP-470 in an in vivo model of hepato- atherosclerosis in Bacillus Calmette-Guerin (BCG)-treated carcinoma is mediated by a p53 and p21“4P "Cl"! mechanism apolipoprotein E-knockout (apo E~‘~) mice (Shibata et al). (Mauriz et al). 2007;149:46-53 2007;149:62-9 Angiopoietin-1 ATP-binding cassette transporters Expression of angiopoietin-| in osteoblasts and its inhibition by Genotypic variation in ATP-binding cassette transporter-1 tumor necrosis factor-alpha and interferon-gamma (Kasama et (ABCA) as contributors to the high and low high-density al). 2007;149:265-73 lipoprotein-chvlesterol (HDL-C) phenotype (Mantaring et al). Angiotensin Il 2007; 149:205-10 Urokinase-type plasminogen activator deficiency (uPA-KO) pre- vented carotid artery ligation-induced vascular remodeling in Attitude of health personnel mice (Martin-McNulty et al). 2007;149:70-5 Are provider self-efficacy and attitudes related to cardiovascular prevention associated with better treatment outcomes? Anoxia Hemodynamic and molecular response to intermittent hypoxia (Litaker et al). 2007;149:165-72 (1H) versus continuous hypoxia (CH) in normal humans (Rod- Autoimmune hepatitis; see Hepatitis, autoimmune way et al). 2007;149:76-84 Anticholesteremic agents Hypocholesterolemic and antioxidative effects of naringenin and Bacillus Calmette-Guerin vaccine; see BCG vaccine its two metabolites in high-cholesterol fed rats (Jeon et al). 2007;149:15-21 Basic helix-loop-helix transcription factors Antigens Transcriptional regulation of podocyte disease (Chugh). 2007; Pathogenesis of autoimmune hepatitis: from break of tolerance to 149:237-42 immune-mediated hepatocyte apoptosis (Lapierre et al). 2007; B-cell non-Hodgkin lymphoma; see Lymphoma, B-cell 149:107-13 (Review) BCG vaccine Anti-inflammatory agents Immunologic response enhances atherosclerosis—type | helper T Antitumor and antiinflammatory effects of tetrathiotungstate in cell (Th1)-to-type 2 helper T cell (Th2) shift and calcified comparison with tetrathiomolybdate (Hou et al). 2007;149: atherosclerosis in Bacillus Calmette-Guerin (BCG)-treated 260-4 apolipoprotein E-knockout (apo E-’) mice (Shibata et al). Antineoplastic agents 2007;149:62-9 Antitumor and antiinflammatory effects of tetrathiotungstate in Bilirubin comparison with tetrathiomolybdate (Hou et al). 2007;149: Solvent partition of '*C-unconjugated bilirubin to remove labeled 260-4 polar contaminants (Ostrow and Mukerjee). 2007;149:37-45 Biological markers ‘January, pp. 1-54; February, pp. 55-102; March, pp. 103-164; April, Cytokine—chemokine and apoptotic signatures in patients with pp. 165-236; May, pp. 237-292; June, pp. 293-342. hepatitis C (Neuman et al). 2007;149:126-36 347 Translational Research 348 Subject Index June 2007 Blood coagulation cell cultures from umbilical cord vessels (De Llano et al). New method to prepare autologous fibrin glue on demand (Alston 2007;149:1-9 et al). 2007;149:187-95 Chelating agents Blood pressure Antitumor and antiinflammatory effects of tetrathiotungstate in Hemodynamic and molecular response to intermittent hypoxia comparison with tetrathiomolybdate (Hou et al). 2007;149: (IH) versus continuous hypoxia (CH) in normal humans (Rod- 260-4 way et al). 2007;149:76-84 Chemokines Breath tests Cytokine—chemokine and apoptotic signatures in patients with Measurement of extra-pancreatic secretory function by '*C- hepatitis C (Neuman et al). 2007;149:126-36 dipeptide breath test (Ishii et al). 2007;149:298-303 Pathogenesis of autoimmune hepatitis: from break of tolerance to immune-mediated hepatocyte apoptosis (Lapierre et al). 2007; 149:107-13 (Review) Cc Cholesterol Cadherins Cholesterol synthesis prevails over absorption in metabolic syn- Cleavage of E-cadherin: a mechanism for disruption of the intes- drome (Gylling et al). 2007;149:310-16 tinal epithelial barrier by Candida albicans (Frank and Cholesterol, dietary Hostetter), 2007;149:211-22 Hypocholesterolemic and antioxidative effects of naringenin and Candida albicans its two metabolites in high-cholesterol fed rats (Jeon et al). Cleavage of E-cadherin: a mechanism for disruption of the intes- 2007;149:15-21 tinal epithelial barrier by Candida albicans (Frank and Cholesterol, HDL Hostetter), 2007;149:21 1-22 Effect of plant sterols and exercise training on cholesterol absorp- Capillaries tion and synthesis in previously sedentary hypercholester- Impaired integration of endothelial progenitor cells in capillaries olemic subjects (Varady et al), 2007;149:22-30 of diabetic wounds is reversible with vascular endothelial Cholesterol, LDL growth factor infusion (Singh et al), 2007;149:282-91 Effect of plant sterols and exercise training on cholesterol absorp- Carbazoles tion and synthesis in previously sedentary hypercholester- Carvedilol, a nonselective B-blocker, suppresses the production olemic subjects (Varady et al). 2007;149:22-30 of tumor necrosis factor and tissue factor by inhibiting early Chronic lymphocytic leukemia; see Leukemia, lymphocytic, growth response factor-! expression in human monocytes in chronic vitro (Mizuochi et al). 2007;149:223-30 Codon Carbon radioisotopes Correlation of K-ras codon |2 mutations in human feces and ages Solvent partition of '“C-unconjugated bilirubin to remove labeled of patients with colorectal cancer (Chien et al). 2007;149:96- polar contaminants (Ostrow and Mukerjee). 2007;149:37-45 102 Carcinoma, renal cell Codon, nonsense SU-011248, a vascular endothelial growth factor receptor-ty- Two novel uroporphyrinogen decarboxylase (URO-D) mutations rosine kinase inhibitor, controls chronic psoriasis (Keshtgar- causing hepatoerythropoietic porphyria (HEP) (Phillips et al). pour and Dudek). 2007;149:103-6 2007;149:85-91 Cardiomyocytes; see Myocytes, cardiac Colorectal neoplasms Cardiovascular diseases Correlation of K-ras codon 12 mutations in human feces and ages Are provider self-efficacy and attitudes related to cardiovascular of patients with colorectal cancer (Chien et al). 2007;149:96- prevention associated with better treatment outcomes? 102 (Litaker et al). 2007;149:165-72 Coronary arteriosclerosis Carotid artery diseases Adiponectin levels are associated with coronary artery disease Urokinase-type plasminogen activator deficiency (uPA-KO) pre- across Caucasian and African-American ethnicity (Lu et al). vented carotid artery ligation-induced vascular remodeling in 2007; 149:317-23 mice (Martin-McNulty et al). 2007;149:70-5 Matrix metalloproteinases in premature coronary atherosclerosis: Carvedilol; see Carbazoles; Propanolamines influence of inhibitors, inflammation, and genetic polymor- Cell adhesion molecules phisms (Nanni et al). 2007;149:137-44 Pathogenesis of autoimmune hepatitis: from break of tolerance to Corrections immune-mediated hepatocyte apoptosis (Lapierre et al). 2007; Differential gene expression identifies subgroups of renal cell 149:107-13 (Review) carcinoma (Skubitz et al) (2006;147:250-67). 2007;149:163 Cell culture techniques Hemodynamic and molecular response to intermittent hypoxia Procedure to consistently obtain endothelial and smooth muscle (1H) versus continuous hypoxia (CH) in normal humans (Rod- cell cultures from umbilical cord vessels (De Llano et al). way et al.) (2007;149:76-84). 2007;149:236 2007; 149:1-9 Cyclin D; see Cyclins Cell proliferation Cyclin-dependent kinase 2 Cell-cycle inhibition by TNP-470 in an in vivo model of hepato- Cell-cycle inhibition by TNP-470 in an in vivo model of hepato- carcinoma is mediated by a p53 and p21“4F'""! mechanism carcinoma is mediated by a p53 and p21““*'"'"' mechanism (Mauriz et al). 2007;149:46-53 (Mauriz et al). 2007;149:46-53 Cell separation Cyclin-dependent kinase 4 Procedure to consistently obtain endothelial and smooth muscle Cell-cycle inhibition by TNP-470 in an in vive model of hepato- Translational Research Volume 149, Number 6 Subject Index 349 carcinoma is mediated by a p53 and p2l WAAFFUII/CC IPI mechanism tion of MalPEG-hemoglobin (MP4) in rhesus monkeys (Mauriz et al). 2007;149:46-53 (Young et al). 2007;149:333-342 Cyclin-dependent kinase inhibitor p21 Dupuytren’s contracture Cell-cycle inhibition by TNP-470 in an in vivo model of hepato- SU-011248, a vascular endothelial growth factor receptor-ty- carcinoma is mediated by a p53 and p21¥“"'“!"! mechanism rosine kinase inhibitor, controls chronic psoriasis (Keshtgar- (Mauriz et al). 2007;149:46-53 pour and Dudek). 2007;149:103-6 Cyclin E; see Cyclins Dust Cyclins Effect of ambient particulate matter exposure on hemostasis Cell-cycle inhibition by TNP-470 in an in vivo model of hepato- (Cozzi et al). 2007;149:324-32 carcinoma is mediated by a p53 and p21““F'“'?! mechanism E (Mauriz et al). 2007;149:46-53 Cytokines Early growth factor-1; see Early growth response protein | Apoptosis in ibuprofen-induced Stevens-Johnson syndrome Early growth response protein 1 (Neuman and Nicar). 2007;149:254-9 Carvedilol, a nonselective B-blocker, suppresses the production Cytokine—chemokine and apoptotic signatures in patients with of tumor necrosis factor and tissue factor by inhibiting early hepatitis C (Neuman et al). 2007;149:126-36 growth response factor-1 expression in human monocytes in Immune dysfunction in inflammatory bowel disease (Neuman). vitro (Mizuochi et al). 2007;149:223-30 2007; 149: 173-86 (Review) E-cadherin; see Cadherins Immunopathogenesis of hypersensitivity syndrome reactions to sulfonamides (Neuman et al). 2007;149:243-53 Electric countershock Irregularity test for very short electrocardiogram (ECG) signals as a method for predicting a successful defibrillation in patients D with ventricular fibrillation (Jagrié et al). 2007;149:145-51 Desmoglein 2 Electrocardiography Cleavage of E-cadherin: a mechanism for disruption of the intes- Irregularity test for very short electrocardiogram (ECG) signals as tinal epithelial barrier by Candida albicans (Frank and a method for predicting a successful defibrillation in patients Hostetter). 2007;149:21 1-22 with ventricular fibrillation (Jagri¢é et al). 2007;149:145-51 Diabetes mellitus Endopeptidases Hemoglobin Alc (HbAlIc) predicts future drug treatment for Cleavage of E-cadherin: a mechanism for disruption of the intes- diabetes mellitus: a follow-up study using routine clinical data tinal epithelial barrier by Candida albicans (Frank and in a Japanese University hospital (Shimazaki et al). 2007;149: Hostetter). 2007;149:211-22 196-204 Endothelial cells Impaired integration of endothelial progenitor cells in capillaries Procedure to consistently obtain endothelial and smooth muscle of diabetic wounds is reversible with vascular endothelial cell cultures from umbilical cord vessels (De Llano et al). growth factor infusion (Singh et al). 2007;149:282-91 2007;149:1-9 Dietary supplements Environmental exposure Nutrigenetics and nutraceuticals: the next wave riding on person- Effect of ambient particulate matter exposure on hemostasis alized medicine (Subbiah). 2007;149:55-61 (Review) (Cozzi et al). 2007;149:324-32 Dipeptides Epidermal necrolysis, toxic Measurement of extra-pancreatic secretory function by '*C- Apoptosis in ibuprofen-induced Stevens-Johnson syndrome dipeptide breath test (Ishii et al). 2007;149:298-303 (Neuman and Nicar). 2007;149:254-9 Disease progression Epithelial cells Noninvasive assessment of fibrosis in non-alcoholic fatty liver Cleavage of E-cadherin: a mechanism for disruption of the intes- disease (NAFLD) and non-alcoholic steatohepatitis (NASH) tinal epithelial barrier by Candida albicans (Frank and (Miele et al). 2007;149:114-25 (Review) Hostetter). 2007;149:21 1-22 Doxorubicin Exercise Antitumor and antiinflammatory effects of tetrathiotungstate in Effect of plant sterols and exercise training on cholesterol absorp- comparison with tetrathiomolybdate (Hou et al). 2007;149: tion and synthesis in previously sedentary hypercholester- 260-4 olemic subjects (Varady et al). 2007;149:22-30 Drug contamination Solvent partition of '*C-unconjugated bilirubin to remove labeled F polar contaminants (Ostrow and Mukerjee). 2007;149:37-45 Fatty liver Drug hypersensitivity Noninvasive assessment of fibrosis in non-alcoholic fatty liver Apoptosis in ibuprofen-induced Stevens-Johnson syndrome disease (NAFLD) and non-alcoholic steatohepatitis (NASH) (Neuman and Nicar). 2007;149:254-9 (Miele et al). 2007;149:114-25 (Review) Immunopathogenesis of hypersensitivity syndrome reactions to Feces sulfonamides (Neuman et al). 2007;149:243-53 Correlation of K-ras codon 12 mutations in human feces and ages Drug tolerance of patients with colorectal cancer (Chien et al). 2007;149:96- Immunopathogenesis of hypersensitivity syndrome reactions to 102 sulfonamides (Neuman et al). 2007;149:243-53 Ferric compounds Drug toxicity Peritoneal effects of intravenous iron sucrose administration in Toxicity and hemodynamic effects after single dose administra- rats (Breborowicz et al). 2007;149:304-9 Translational Research 350 Subject index June 2007 Fibrin glue; see Fibrin tissue adhesive a method for predicting a successful defibrillation in patients Fibrinogen with ventricular fibrillation (Jagri¢é et al). 2007;149:145-51 New method to prepare autologous fibrin glue on demand (Alston Hemochromatosis et al). 2007;149:187-95 Hemochromatosis (HFE) gene splice site mutation IVS5+1 G/A Fibrin tissue adhesive in North American Vietnamese with and without phenotypic New method to prepare autologous fibrin glue on demand (Alston evidence of iron overload (Steiner et al). 2007;149:92-5 et al). 2007;149:187-95 Hemodynamics Fibroblasts Toxicity and hemodynamic effects after single dose administra- Advanced glycation end-product-induced mitogenesis is depen- tion of MalPEG-hemoglobin (MP4) in rhesus monkeys dent on Janus kinase 2-induced heat shock protein 70 in (Young et al). 2007;149:333-342 normal rat kidney interstitial fibroblast cells (Chen et al). Hemoglobin A, glycosylated 2007;149:274-81 Hemoglobin Alc (HbAlIc) predicts future drug treatment for Fibrosis diabetes mellitus: a follow-up study using routine clinical data Cytokine—chemokine and apoptotic signatures in patients with in a Japanese University hospital (Shimazaki et al). 2007; 149: hepatitis C (Neuman et al). 2007;149:126-36 196-204 Noninvasive assessment of fibrosis in non-alcoholic fatty liver Hemoglobin Alc; see Hemoglobin A, glycosylated; Protein precur- disease (NAFLD) and non-alcoholic steatohepatitis (NASH) (Miele et al). 2007;149:114-25 (Review) sors Hemoglobins Flavanones Hypocholesterolemic and antioxidative effects of naringenin and Toxicity and hemodynamic effects after single dose administra- its two metabolites in high-cholesterol fed rats (Jeon et al). tion of MalPEG-hemoglobin (MP4) in rhesus monkeys 2007;149:15-21 (Young et al). 2007;149:333-342 Free light chains; see Immunoglobulin light chains Hemostasis Effect of ambient particulate matter exposure on hemostasis G (Cozzi et al). 2007;149:324-32 Hepatitis, autoimmune Genes, ras Pathogenesis of autoimmune hepatitis: from break of tolerance to Correlation of K-ras codon 12 mutations in human feces and ages immune-mediated hepatocyte apoptosis (Lapierre et al). 2007; of patients with colorectal cancer (Chien et al). 2007;149:96- 102 149:107-13 (Review) Genetic polymorphism; see Polymorphism, genetic Hepatitis C Cytokine—chemokine and apoptotic signatures in patients with Glucose hepatitis C (Neuman et al). 2007;149:126-36 Cholesterol synthesis prevails over absorption in metabolic syn- drome (Gylling et al). 2007;149:310-16 Hepatocyte growth factor Cell-cycle inhibition by TNP-470 in an in vivo model of hepato- Glycosylation end-products, advanced carcinoma is mediated by a p53 and p21““"'“'"' mechanism Advanced glycation end-product-induced mitogenesis is depen- dent on Janus kinase 2-induced heat shock protein 70 in (Mauriz et al). 2007;149:46-53 normal rat kidney interstitial fibroblast cells (Chen et al). Hepatocytes 2007;149:274-81 Pathogenesis of autoimmune hepatitis: from break of tolerance to Granulocyte colony-stimulating factor immune-mediated hepatocyte apoptosis (Lapierre et al). 2007; Ethnic differences in plasma levels of interleukin-8 (IL-8) and 149:107-13 (Review) granulocyte colony stimulating factor (G-CSF) (Mayr et al). Hepatoerythropoietic porphyria; see Porphyria, hepatoerythropoi- 2007; 149: 10-4 etic High-density lipoprotein-cholesterol; see Lipoproteins, HDL cho- lesterol Head and neck neoplasms Homeodomain proteins The role of acetaldehyde in upper digestive tract cancer in alco- Transcriptional regulation of podocyte disease (Chugh). 2007; holics (Seitz and Meier). 2007;149:293-7 149:237-42 Health personnel Homeostasis Are provider self-efficacy and attitudes related to cardiovascular Peritoneal effects of intravenous iron sucrose administration in prevention associated with better treatment outcomes? rats (Breborowicz et al). 2007;149:304-9 (Litaker et al). 2007;149:165-72 HSP70 heat-shock proteins Heart failure, congestive Advanced glycation end-product-induced mitogenesis is depen- Carvedilol, a nonselective B-blocker, suppresses the production dent on Janus kinase 2-induced heat shock protein 70 in of tumor necrosis factor and tissue factor by inhibiting early normal rat kidney interstitial fibroblast cells (Chen et al). growth response factor-1 expression in human monocytes in 2007;149:274-81 vitro (Mizuochi et al). 2007;149:223-30 Human genome project Heart rate Nutrigenetics and nutraceuticals: the next wave riding on person- Hemodynamic and molecular response to intermittent hypoxia alized medicine (Subbiah). 2007;149:55-61 (Review) (IH) versus continuous hypoxia (CH) in normal humans (Rod- way et al). 2007;149:76-84 p-Hydroxybenzoic acid; see Parabens Irregularity test for very short electrocardiogram (ECG) signals as p-Hydroxyphenylpropionic acid; see Phenylpropionates Translational Research Volume 149, Number 6 Subject Index 351 Hypercholesterolemia granulocyte colony stimulating factor (G-CSF) (Mayr et al). Effect of plant sterols and exercise training on cholesterol absorp- 2007; 149:10-4 tion and synthesis in previously sedentary hypercholester- Intestinal absorption olemic subjects (Varady et al). 2007;149:22-30 Effect of plant sterols and exercise training on cholesterol absorp- Hypoglycemic agents tion and synthesis in previously sedentary hypercholester- Hemoglobin Alc (HbAlIc) predicts future drug treatment for olemic subjects (Varady et al). 2007;149:22-30 diabetes mellitus: a follow-up study using routine clinical data Intestinal mucosa in a Japanese University hospital (Shimazaki et al). 2007;149: Cleavage of E-cadherin: a mechanism for disruption of the intes- 196-204 tinal epithelial barrier by Candida albicans (Frank and Hypoxia; see Anoxia Hostetter). 2007;149:21 1-22 Immune dysfunction in inflammatory bowel disease (Neuman). 2007; 149:173-86 (Review) Iron overload Ibuprofen Hemochromatosis (HFE) gene splice site mutation IVS5+1 G/A Apoptosis in ibuprofen-induced Stevens-Johnson syndrome in North American Vietnamese with and without phenotypic (Neuman and Nicar). 2007;149:254-9 evidence of iron overload (Steiner et al). 2007;149:92-5 Immune system Iron sucrose; see Ferric compounds Immune dysfunction in inflammatory bowel disease (Neuman). Ischemia 2007;149:173-86 (Review) Trimetazidine inhibits cardiomyocyte apoptosis in a rabbit model Immune tolerance of ischemia-reperfusion (Ruixing et al). 2007;149:152-60 Pathogenesis of autoimmune hepatitis: from break of tolerance to immune-mediated hepatocyte apoptosis (Lapierre et al). 2007; J 149:107-13 (Review) Janus kinase 2; see Protein-tyrosine kinase; Proto-oncogene proteins Immunity, mucosal K Immune dysfunction in inflammatory bowel disease (Neuman). 2007;149:173-86 (Review) Keratinocytes Immunoglobulin light chains Apoptosis in ibuprofen-induced Stevens-Johnson syndrome Serum-free light chain—a new biomarker for patients with B-cell (Neuman and Nicar). 2007;149:254-9 non-Hodgkin lymphoma and chronic lymphocytic leukemia Kidney (Martin et al). 2007;149:231-5 Advanced glycation end-product-induced mitogenesis is depen- Immunoglobulin M dent on Janus kinase 2-induced heat shock protein 70 in Serum-free light chain—a new biomarker for patients with B-cell normal rat kidney interstitial fibroblast cells (Chen et al). non-Hodgkin lymphoma and chronic lymphocytic leukemia 2007; 149:274-81 (Martin et al). 2007;149:231-5 Kidney diseases Indoles Transcriptional regulation of podocyte disease (Chugh). 2007; SU-011248, a vascular endothelial growth factor receptor-ty- 149:237-42 rosine kinase inhibitor, controls chronic psoriasis (Keshtgar- Kreisler; see MAFB transcription factor pour and Dudek). 2007;149:103-6 L Inflammation Cytokine—chemokine and apoptotic signatures in patients with Leukemia, lymphocytic, chronic hepatitis C (Neuman et al). 2007;149:126-36 Serum-free light chain—a new biomarker for patients with B-cell Immune dysfunction in inflammatory bowel disease (Neuman). non-Hodgkin lymphoma and chronic lymphocytic leukemia 2007;149:173-86 (Review) (Martin et al). 2007;149:231-5 Matrix metalloproteinases in premature coronary atherosclerosis: Ligation influence of inhibitors, inflammation, and genetic polymor- Urokinase-type plasminogen activator deficiency (uPA-KO) pre- phisms (Nanni et al). 2007;149:137-44 vented carotid artery ligation-induced vascular remodeling in Noninvasive assessment of fibrosis in non-alcoholic fatty liver mice (Martin-McNulty et al). 2007;149:70-5 disease (NAFLD) and non-alcoholic steatohepatitis (NASH) LIM homeobox transcription factor 1, beta; see Homeodomain (Miele et al). 2007;149:114-25 (Review) proteins; Transcription factors Inflammatory bowel diseases Lipopolysaccharides Immune dysfunction in inflammatory bowel disease (Neuman). Carvedilol, a nonselective B-blocker, suppresses the production 2007; 149:173-86 (Review) of tumor necrosis factor and tissue factor by inhibiting early Infusions, intravenous growth response factor-1 expression in human monocytes in Peritoneal effects of intravenous iron sucrose administration in vitro (Mizuochi et al). 2007;149:223-30 rats (Breborowicz et al). 2007;149:304-9 Lipoproteins, HDL cholesterol Interferon-gamma; see Interferon type II Genotypic variation in ATP-binding cassette transporter-| Interferon type II (ABCA]) as contributors to the high and low high-density Expression of angiopoietin-1 in osteoblasts and its inhibition by lipoprotein-cholesterol (HDL-C) phenotype (Mantaring et al). tumor necrosis factor-alpha and interferon-gamma (Kasama et 2007; 149:205-10 al). 2007;149:265-73 Liver cirrhosis Interleukin-8 Cytokine—chemokine and apoptotic signatures in patients with Ethnic differences in plasma levels of interleukin-8 (IL-8) and hepatitis C (Neuman et al). 2007;149:126-36 Translational Research 352 Subject Index June 2007 Noninvasive assessment of fibrosis in non-alcoholic fatty liver cell cultures from umbilical cord vessels (De Llano et al). disease (NAFLD) and non-alcoholic steatohepatitis (NASH) 2007;149:1-9 (Miele et al). 2007;149:114-25 (Review) Liver neoplasms, experimental Cell-cycle inhibition by TNP-470 in an in vivo model of hepato- Naringenin; see Flavanones carcinoma is mediated by a p53 and p21 ¥4F'“'"! mechanism (Mauriz et al). 2007;149:46-53 Neoplasm recurrence, local SU-011248, a vascular endothelial growth factor receptor-ty- Lymphocytes rosine kinase inhibitor, controls chronic psoriasis (Keshtgar- Apoptosis in ibuprofen-induced Stevens-Johnson syndrome pour and Dudek). 2007;149:103-6 (Neuman and Nicar). 2007;149:254-9 Immunopathogenesis of hypersensitivity syndrome reactions to Neoplasms Antitumor and antiinflammatory effects of tetrathiotungstate in sulfonamides (Neuman et al). 2007;149:243-53 comparison with tetrathiomolybdate (Hou et al). 2007:149: Lymphoma, B-cell 260-4 Serum-free light chain—a new biomarker for patients with B-cell NF-kappa B non-Hodgkin lymphoma and chronic lymphocytic leukemia Transcriptional regulation of podocyte disease (Chugh). 2007; (Martin et al). 2007;149:231-5 149:237-42 Nitric-oxide synthase M Hemodynamic and molecular response to intermittent hypoxia MABSB transcription factor (IH) versus continuous hypoxia (CH) in normal humans (Rod- Transcriptional regulation of podocyte disease (Chugh). 2007; way et al). 2007;149:76-84 149:237-42 Nuclear factor-KB; see NF-kappa B Maleimide-polyethylene glycol-modified hemoglobin (MP4); see Nutrition physiology Hemoglobins; Maleimides Nutrigenetics and nutraceuticals: the next wave riding on person- Maleimides alized medicine (Subbiah). 2007;149:55-61 (Review) Toxicity and hemodynamic effects after single dose administra- Nutrition therapy tion of MalPEG-hemoglobin (MP4) in rhesus monkeys Nutrigenetics and nutraceuticals: the next wave riding on person- (Young et al). 2007;149:333-342 alized medicine (Subbiah). 2007;149:55-61 (Review) Matrix metalloproteinases Matrix metalloproteinases in premature coronary atherosclerosis: oO influence of inhibitors, inflammation, and genetic polymor- Occludin; see Membrane proteins phisms (Nanni et al). 2007;149:137-44 Osteoblasts Membrane proteins Expression of angiopoietin-! in osteoblasts and its inhibition by Cleavage of E-cadherin: a mechanism for disruption of the intes- tumor necrosis factor-alpha and interferon-gamma (Kasama et tinal epithelial barrier by Candida albicans (Frank and al). 2007;149:265-73 Hostetter). 2007;149:211-22 Oxidative stress Metabolic syndrome Advanced glycation end-product-induced mitogenesis is depen- Cholesterol synthesis prevails over absorption in metabolic syn- dent on Janus kinase 2-induced heat shock protein 70 in drome (Gylling et al). 2007;149:310-16 normal rat kidney interstitial fibroblast cells (Chen et al). Mitosis 2007; 149:274-81 Advanced glycation end-product-induced mitogenesis is depen- dent on Janus kinase 2-induced heat shock protein 70 in normal rat kidney interstitial fibroblast cells (Chen et al). 2007; 149:274-8 1 Pancreatic function tests Molybdenum Measurement of extra-pancreatic secretory function by '*C- Antitumor and antiinflammatory effects of tetrathiotungstate in o dipeptide breath test (Ishii et al). 2007;149:298-303 comparison with tetrathiomolybdate (Hou et al). 2007;149: Pancreatitis, chronic 260-4 Measurement of extra-pancreatic secretory function by '*C- Monocytes dipeptide breath test (Ishii et al). 2007;149:298-303 Carvedilol, a nonselective B-blocker, suppresses the production Parabens of tumor necrosis factor and tissue factor by inhibiting early Hypocholesterolemic and antioxidative effects of naringenin and growth response factor-] expression in human monocytes in its two metabolites in high-cholesterol fed rats (Jeon et al). vitro (Mizuochi et al). 2007;149:223-30 2007;149:15-21 Mutation, missense PAX2 transcription factor Two novel uroporphyrinogen decarboxylase (URO-D) mutations Transcriptional regulation of podocyte disease (Chugh). 2007; causing hepatoerythropoietic porphyria (HEP) (Phillips et al). 149:237-42 2007;149:85-91 Peritoneal dialysis, continuous ambulatory Myocytes, cardiac Peritoneal effects of intravenous iron sucrose administration in Trimetazidine inhibits cardiomyocyte apoptosis in a rabbit model rats (Breborowicz et al). 2007;149:304-9 of ischemia-reperfusion (Ruixing et al). 2007;149:152-60 Pharmacogenetics Myocytes, smooth muscle Nutrigenetics and nutraceuticals: the next wave riding o1 person- Procedure to consistently obtain endothelial and smooth muscle alized medicine (Subbiah). 2007;149:55-61 (Review)